GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...
If you have been NEWLY DIAGNOSED START HERE
VIDEOS
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018...
ARTICLES
Dr. Ben Levy discusses two trials that are trying to determine if immunotherapy can help lung cancer patients with earlier stage disease. Click here for information about the PACIFIC trial. The lung cancer vaccine trial will begin in early 2016.
Dr. Nathan Pennell discusses ALCHEMIST, an NCI-sponsored clinical trial looking at whether targeted post-op (adjuvant) therapy for patients with a driver mutation such as EGFR mutation or ALK rearrangement improves survival.
ROS1 lung cancer patient Lisa Goldman credits research with keeping her alive. November is Lung Cancer Awareness Month. What are you grateful for?
Drs. Leora Horn, Ben Solomon, & Jack West consider whether the data suggest that the better tested PD1 and PD-L1 inhibitors have differences in activity or tolerability or are essentially interchangeable.
MSKCC medical oncologist Dr. Greg Riely reviews the optimal first line treatment of patients with an EGFR mutation-positive advanced lung cancer.